Your session is about to expire
← Back to Search
Expressive Helping for Stem Cell Transplantation
Phase 3
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12-month post-intervention
Awards & highlights
Study Summary
This trial is testing whether a writing intervention can help ease the psychological stress of adults undergoing hematopoietic stem cell transplantation.
Eligible Conditions
- Stem Cell Transplantation
- Blood Cancers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12-month post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12-month post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Cancer-specific anxiety: Changes in symptoms of cancer-specific anxiety
Depressive symptoms: Changes in depressive symptoms
Fatigue: Changes in fatigue
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Expressive Helping writingExperimental Treatment1 Intervention
Writing sessions 1-3: Participants complete one 20-minute expressive writing session at three time points: 1) after hospitalization but prior to transplant infusion, (2) approximately 3 days after hospital discharge, and (3) approximately 2 weeks after completion of writing session 2.
Writing session 4: One 20-40 minute peer support writing session about 1 week after completion of writing session 3.
Group II: Factual WritingActive Control1 Intervention
Writing sessions 1-3: Participants complete one 20-minute factual session at three time points: 1) after hospitalization but prior to transplant infusion, (2) approximately 3 days after hospital discharge, and (3) approximately 2 weeks after completion of writing session 2.
Writing session 4: One 20-40 minute factual writing session about 1 week after completion of writing session 3.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Expressive Helping
2022
Completed Phase 3
~710
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,846 Total Patients Enrolled
Hackensack Meridian HealthOTHER
131 Previous Clinical Trials
27,839 Total Patients Enrolled
Lombardi Comprehensive Cancer CenterOTHER
6 Previous Clinical Trials
749 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are we looking for more participants for this experiment?
"Unfortunately, this particular clinical trial is no longer looking for patients. It was first posted on March 6th 2019 and updated for the last time on June 9th 2022. However, there are many other medical trials that are still recruiting individuals. In fact, 287 other studies are actively searching for participants as we speak."
Answered by AI
What are the risks and benefits of Expressive Helping?
"Expressive Helping has received a score of 3 from our team at Power. This is because Expressive Helping is a Phase 3 trial, meaning that there is data supporting both its efficacy and safety."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger